Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope.
Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope. The company does this by discovering what's inherent in our biology about the unexplained and translating discoveries into personal insights that inform actions.Inherent Biosciences develops medicines for treating pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and many more.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 17, 2021 | Seed | — | 2 | Morning Star Foundation | — | Detail |
Sep 9, 2020 | Grant | $255.95K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Morning Star Foundation | Yes | Seed |
National Science Foundation | Yes | Grant |
Park City Angels | — | Seed |